Recent studies demonstrated that SNAs with liposomal cores that carry CpG oligonucleotides activate TLR9 more potently when compared to linear oligonucleotides and show remarkable activity against murine lymphoma due to multivalent, high-affinity binding to TLR9 [56]. This evidence concerns the gene TLR9 and lymphoma.